NASDAQ:CFLT • US20717M1036
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CONFLUENT INC-CLASS A (CFLT).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-23 | Bernstein | Downgrade | Outperform -> Market Perform |
| 2026-01-09 | Citizens | Downgrade | Market Outperform -> Market Perform |
| 2025-12-10 | Guggenheim | Downgrade | Buy -> Neutral |
| 2025-12-09 | DA Davidson | Downgrade | Buy -> Neutral |
| 2025-12-09 | UBS | Downgrade | Buy -> Neutral |
| 2025-12-09 | Needham | Downgrade | Buy -> Hold |
| 2025-12-09 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2025-12-09 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2025-12-09 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2025-12-09 | Baird | Maintains | Neutral -> Neutral |
| 2025-12-09 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2025-12-09 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-12-08 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-12-08 | DA Davidson | Maintains | Buy -> Buy |
| 2025-12-08 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-10-29 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-10-28 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-10-28 | DA Davidson | Maintains | Buy -> Buy |
| 2025-10-28 | UBS | Maintains | Buy -> Buy |
| 2025-10-28 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-10-28 | Stephens & Co. | Maintains | Overweight -> Overweight |
| 2025-10-28 | Stifel | Maintains | Hold -> Hold |
| 2025-10-28 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-28 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-28 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 776.952M 32.61% | 963.642M 24.03% | 1.167B 21.08% | 1.385B 18.71% | 1.619B 16.90% | 1.861B 14.95% | 2.141B 15.05% | 2.335B 9.06% | 2.632B 12.72% | 2.95B 12.08% | |
| EBITDA YoY % growth | -430.009M 5.51% | -397.058M 7.66% | -350.546M 11.71% | 164.54M 146.94% | 243.48M 47.98% | 292.84M 20.27% | 434.16M 48.26% | 501.53M 15.52% | 612.82M 22.19% | 731.34M 19.34% | |
| EBIT YoY % growth | -443.919M 4.06% | -419.147M 5.58% | -380.102M 9.32% | 137.87M 136.27% | 211.09M 53.11% | 308.58M 46.18% | 407.64M 32.10% | 467.16M 14.60% | 577.32M 23.58% | 694.62M 20.32% | |
| Operating Margin | -57.14% | -43.50% | -32.58% | 9.95% | 13.04% | 16.58% | 19.04% | 20.01% | 21.93% | 23.55% | |
| EPS YoY % growth | 0.02 103.51% | 0.30 1,400.00% | 0.42 40.00% | 0.49 16.67% | 0.66 34.80% | 0.83 25.60% | 1.09 30.95% | 1.22 12.68% | 1.40 14.17% | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.10 30.19% | 0.12 32.03% | 0.14 4.71% | 0.14 12.95% | 0.13 23.95% | 0.15 22.93% | 0.17 23.04% | 0.17 23.58% |
| Revenue Q2Q % growth | 324.29M 19.61% | 337.32M 19.50% | 352.88M 18.21% | 366.43M 16.39% | 375.87M 15.91% | 391.45M 16.05% | 409.02M 15.91% | 425.81M 16.21% |
| EBITDA Q2Q % growth | 32.246M 134.10% | 38.252M 146.37% | 46.391M 175.38% | 49.119M 170.56% | 52.25M 62.04% | 56.656M 48.11% | 70.395M 51.74% | 69.166M 40.81% |
| EBIT Q2Q % growth | 26.017M 125.71% | 31.559M 132.72% | 38.267M 145.93% | 38.452M 138.77% | 39.398M 51.43% | 46.233M 46.50% | 54.542M 42.53% | 55.553M 44.47% |
All data in USD
33 analysts have analysed CFLT and the average price target is 30.82 USD. This implies a price increase of 0.22% is expected in the next year compared to the current price of 30.75.
CONFLUENT INC-CLASS A (CFLT) will report earnings on 2026-04-28, after the market close.
The consensus EPS estimate for the next earnings of CONFLUENT INC-CLASS A (CFLT) is 0.1 USD and the consensus revenue estimate is 324.29M USD.
The number of analysts covering CONFLUENT INC-CLASS A (CFLT) is 33.